Biweekly peglated liposomal doxorubicin/oxaliplatin for ovarian cancer resistant to taxane-platinum treatment: a Phase II study. [electronic resource]
Producer: 20121231Description: 169-75 p. digitalISSN:- 1998-4774
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bridged-Ring Compounds -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm -- genetics
- Female
- Humans
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Oxaliplatin
- Survival Analysis
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.